Dattijan dopamine D₂ / D₃ mai ɗaukar nauyi a cikin caca da aka haɗu da shi an haɗa shi ne tare da impulsivity-related impotivity (2012)

Hoton Jijiyoyi. 15 ga Oktoba, 2012;63(1):40-6. doi: 10.1016/j.neuroimage.2012.06.067. Epub 2012 Yuli 6.

Clark L , Stokes PR , Wu K , Michalczuk R , Benecke A , Watson BJ , Egerton A , Piccini P , Nutt DJ , Bowden-Jones H , Lingford-Hughes AR.

source

Sashen Nazarin Ilimin Halayyar Dan Adam, Jami'ar Cambridge, Cambridge, Birtaniya. [email protected]

Abstract

Caca ta hanyar cututtuka (PG) jaraba ce ta ɗabi'a da ke da alaƙa da hauhawar sha'awa da kuma zargin rashin daidaituwar dopamine . An bayar da rahoton raguwar samuwar masu karɓar dopamine D(2)/D(3) a cikin jarabar miyagun ƙwayoyi, kuma yana iya zama alamar rauni ta farko ga cututtukan jaraba.

Manufar wannan binciken ita ce a tantance samuwar masu karɓar dopamine D(2)/D(3) a cikin PG, da kuma alaƙarsa da rashin ƙarfin hali. Maza masu fama da PG (n=9) da kuma maza masu lafiya (n=9) an yi musu hoton [11C]-raclopride positron emission tomography kuma sun kammala sikelin impulsivity na UPPS-P.

Babu wani bambanci mai mahimmanci tsakanin ƙungiyoyi a cikin samuwar masu karɓar dopamine D(2)/D(3) , sabanin rahotannin da suka gabata game da jarabar miyagun ƙwayoyi.

Duk da haka, rashin sha'awar yanayi ('Gaggawa') yana da alaƙa mara kyau da yuwuwar ɗaure [11C]-raclopride a cikin ƙungiyar PG. Rashin bambancin rukuni a cikin ɗaure dopamine na striatal yana nuna bambanci tsakanin jarabar ɗabi'a da jarabar miyagun ƙwayoyi. Duk da haka, bayananmu suna nuna bambancin samuwar masu karɓar dopamine a cikin caca mara tsari , ta yadda mutanen da ke da sha'awar yanayi mai yawa na iya nuna fa'idodi daban-daban daga magungunan da aka dogara da dopamine.

Kalmomi Masu Mahimmanci: Caca, Ƙarfin Hankali, Dopamine, Neuroimaging, Addiction, Striatum

Ka tafi zuwa ga:

labarai

► Gane da 11C-raclopride mai ɗaure a cikin caca da keɓaɓɓiyar cuta, jaraba game da dabi'a. ► Babu bambancin kungiya a cikin ɗawainiyar dopamine mai ɗauri daga sarrafawa mai lafiya. ► Dopamine dauri ba ta da dangantaka da abinda ke haifar da yanayi ('Gaggawar gaggawa').

Ka tafi zuwa ga:

Gabatarwa

Cutar Pathological caca (PG) shine rikicewar rikicewar DSM-IV tare da babban ɗakunan asibiti da haɗarin ƙwaƙwalwar ƙwayar cuta tare da jaraba, yana haifar da sake-ra'ayi na PG a matsayin 'jaraba na halayyar' (Bowden-Jones da Clark, 2011; Frascella et al., 2010). Tsarin cututtukan ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa yana ƙarfafa dysregulation na dopamine: kwayoyi da yawa na zagi suna tayar da neuropransmission dopamine (Di Chiara da Imperato, 1988), da ragi a cikin dopamine D2/D3 An bayyana wadatar mai karɓa a cikin marasa lafiya da dogaro da kwayoyi da yawa da aka lalata (Fehr et al., 2008; Heinz et al., 2004; Martinez et al., 2004; Volkow et al., 1997, 2001). Ba a sani ba ko waɗannan canje-canjen suna nuna sakamakon amfani da miyagun ƙwayoyi na dogon lokaci, ko kuma kasancewar yanayin cutarwar da ke tattare da maye. Ya dace da alamar rauni, 'likitan magunguna' ana danganta su da ƙananan D2/D3 karbar mai karɓa (Volkow et al., 1999), da ƙarancin ƙwaƙwalwar ƙwaƙwalwa da aka haifar da kasancewa da halayyar ɗabi'a don nuna cikakkiyar saurin mallakin sarrafa hodar iblis da rage dopamine2/D3 mai karɓar mai karɓa kafin bayyanar miyagun ƙwayoyi (Dalley et al., 2007). A matsayin nau'i na jaraba tare da mai guba mai saurin sakaci, bincike na PG na iya ba da damar kara nazarin yanayin yanayin yanayin rashin haɗari a cikin mutane, da kuma taimakawa sasanta abubuwan da ke haifar da sakamako (sakamakon)Verdejo-Garcia et al., 2008). Tabbas, akwai da yawa alamomi na dopamine dysregulation a cikin PG. Alamar dopamine na cikin mahaifa a cikin mahaukata matsala (Bergh et al., 1997; Meyer et al., 2004), kamar yadda amsar fMRI a cikin kewayon dopamine-mai arziki yayin aiwatarwa akan ayyukan caca (Chase da Clark, 2010; Reuter et al., 2005), kodayake jagorancin sakamako bai dace ba. Bugu da kari, magungunan kwayar-kwayar cutar kwayar cutar ta kwayar cutar ta Parkinson suna da ikon haifar da caca ta rikice a matsayin sakamako mai tasiri (Voon et al., 2009).

Hoton Positron Emission Tomography (PET) tare da [11C]-raclopride yana ba da hanyar auna watsawar dopamine mai ƙarfi a cikin kwakwalwar ɗan adam mai rai. An yi amfani da [11C]-raclopride kwanan nan a cikin nazarin PET guda huɗu da aka yi wa masu halartar caca marasa tsari a cikin ƙira mai ƙarfi (watau waɗanda suka shafi aiki) ( Joutsa et al., 2012; Linnet et al., 2011; O'Sullivan et al., 2011; Steeves et al., 2009 ). Biyu daga cikin waɗannan nazarin sun kasance a cikin marasa lafiya da ke fama da cutar Parkinson ( O'Sullivan et al., 2011; Steeves et al., 2009 ), inda har yanzu ba a san yadda kewayon rikice-rikicen sarrafa sha'awa ke da alaƙa da aikin jijiyoyi na farko na cutar ba ( Voon et al., 2009 ). Sauran binciken guda biyu, a cikin babban PG, duka sun yi amfani da ayyuka masu rikitarwa na yanke shawara / caca inda gwajin farko ya ƙunshi aikin sarrafa firikwensin ( Joutsa et al., 2012; Linnet et al., 2011 ). Bincike ɗaya kawai ( Steeves et al., 2009 ) ya sami shaida don rage samuwar dopamine D2 /D3 mai karɓar sigina a cikin ƙungiyar da ke da matsalar caca. Wannan binciken ya binciki samuwar dopamine D2 /D3 mai karɓar sigina a cikin marasa lafiya da ke neman magani tare da ganewar asali na PG, inda muka yi hasashen raguwar samuwar D2 / D3 mai karɓar sigina bisa ga binciken da aka yi a baya a cikin jarabar miyagun ƙwayoyi.

Mun kuma nemi bincika samuwar masu karɓar D2 /D3 masu tsauri dangane da rashin ƙarfin hali. Ana lura da hauhawar sha'awa a cikin jarabar miyagun ƙwayoyi da PG ( Verdejo-Garcia et al., 2008 ), kuma ana ganin yana hasashen ci gaban matsalolin amfani da miyagun ƙwayoyi da caca ( Slutske et al., 2005 ). Kwanan nan mun yi amfani da sikelin rashin ƙarfin hali na UPPS-P ( Cyders et al., 2007 ) don tantance ƙananan ɓangarorin tsarin rashin ƙarfin hali a cikin marasa lafiya da PG da ke halartar Asibitin Caca na Ƙasa na Burtaniya ( Michalczuk et al., 2011 ). An lura da manyan bambance-bambance tsakanin ƙungiyar PG da kula da lafiya akan wasu ƙananan ma'auni na UPPS-P ciki har da Gaggawa - yanayin yin saurin kai hari yayin yanayin yanayi mara kyau ko mai kyau ('rashin ƙarfin kai') - da kuma ɓangarorin 'raƙuman' sha'awa (Rashin Tsarin da Rashin Juriya). Duk da haka, girman tasirin bambance-bambancen gaggawa ya fi na ƙananan fuskokin sha'awa, wanda hakan ya haifar da ƙarshe cewa sha'awa da ke da alaƙa da yanayi yana da mahimmanci musamman a cikin mahallin caca mara tsari ( Michalczuk et al., 2011 ). Dangane da waɗannan abubuwan da aka lura, nazarin bambance-bambancen da muka yi ya mayar da hankali kan ƙananan ma'auni guda biyu na gaggawa (Gaggawa mara kyau da Gaggawa Mai Kyau) a matsayin masu hasashen.

Ka tafi zuwa ga:

Hanyoyi da kayan

Wanda su ka Halarta

An kwatanta maza tara masu aikin sa kai da PG (matsakaicin shekaru 35.3, sd 9.0, kewayon 25-49) da maza tara masu lafiya (matsakaicin shekaru 37.2, sd 5.6, kewayon 30-46). An ɗauki mutum na goma da ke da PG amma ba a samu don yin nazari ba saboda gazawar kimiyyar rediyo. An gano na'urorin auna sa kai na farko daga bincike biyu da suka gabata ( Egerton et al., 2010; Stokes et al., 2010 ) ta amfani da bayanai na yau da kullun na na'urorin auna raclopride da aka gudanar a Cibiyar Kimiyyar Asibiti ta MRC, kuma bai bambanta da ƙungiyar PG a cikin shekaru ba (t 16 = 0.53, p = .602). An ilmantar da mahalarta PG har zuwa matakin sakandare tare da kimantawar IQ a cikin kewayon lafiya (Wechsler Adult Scale for Intelligence: ma'ana 116, sd 10.8; Gwajin Karatun Manyan Kasa: ma'ana 117, sd 5.7); Aikin da ya gabata ya nuna babu wata alaƙa mai daidaito tsakanin matakan hankali da kuma matakan ɗaure dopamine. Duk masu sa kai sun bayar da izini a rubuce don binciken, wanda Kwamitin Ɗabi'a na Bincike na Hammersmith da Kwamitin Ba da Shawara kan Gudanar da Abubuwan Radiogenic, Burtaniya suka amince da shi.

An ɗauki mahalarta PG daga Asibitin Caca na Matsalar Ƙasa, Central North West London NHS Foundation Trust. An ɗauki hotunan masu sa kai shida jim kaɗan kafin, ko kuma a lokacin, wani kwas na zaman motsa jiki na fahimta da ɗabi'a guda goma, kuma uku sun kammala magani kwanan nan. Duk masu sa kai tara suna da tarihin yin caca na baya-bayan nan. An tabbatar da gano cutar DSM-IV ta PG ta amfani da Allon Caca na Massachusetts (MAGS; matsakaicin 9.8, sd 2.2, kewayon 5-12) ( Shaffer et al., 1994 ), wanda mataimakin masanin ilimin halayyar ɗan adam ya gudanar a lokacin fara magani. An tabbatar da ganewar cutar tare da Ma'aunin Tsananin Caca na Matsalar ( Ferris da Wynne, 2001 ), ma'aunin rahoton kai wanda aka bayar a farkon magani (matsakaicin 18.4, sd 5.7, kewayon 8-24; maki 8 ko sama da haka yana nuna matsalar caca). Jinkiri tsakanin kimantawar asibiti da gwajin PET shine watanni 2-8 a cikin mahalarta 8/9, da watanni 23 a cikin PG ɗaya wanda aka duba bayan magani. An tantance cututtukan da suka shafi tabin hankali a cikin mahalarta PG ta hanyar wata hira mai tsari ta amfani da ICD-10, tare da sigar kwamfuta ta Mini International Neuropsychiatric Interview (e-MINI v2.0; Medical Outcome Systems, Jacksonville, Florida) ( Sheehan et al., 1998 ). Masu sa kai biyu suna da tarihin babban rashin jin daɗi a baya, kuma wani mai sa kai ya cika sharuɗɗa don babban rashin jin daɗi na yanzu da na rayuwa. Ɗaya daga cikin masu sa kai ya cika sharuɗɗa don dogaro da barasa a baya, kuma na biyu ya cika sharuɗɗa don dogaro da cannabis a baya. Masu sa kai huɗu sun kasance masu shan sigari a yanzu a lokacin ɗaukar ma'aikata zuwa binciken (Matsakaicin Fagerstrom Nicotine Dependence Scale daga 6 zuwa 12). Sharuɗɗan keɓewa ga ƙungiyar PG sune: tarihin cututtukan jijiyoyi, shigar da tabin hankali a baya, maganin magunguna na yanzu da kuma manyan cututtukan jiki. Saboda haka, cututtukan tabin hankali da aka gano ba su da isasshen tsanani don buƙatar shiga tsakani na asibiti. An riga an tantance duk mahalarta kula da lafiyar kwakwalwa ta hanyar likitan tabin hankali don cire matsalolin lafiyar kwakwalwa na yanzu ko na baya, da dogaro da sinadarai kamar yadda DSM-IV ta bayyana, rashin lafiya mai tsanani, cututtukan jijiyoyi na baya ko amfani da magungunan psychotropic a baya.

An tantance ayyukan caca a cikin mahalarta PG ta amfani da abubuwa 1-3 akan Allon Caca na South Oaks ( Lesieur da Blume, 1987 ). Mahalarta shida sun ɗauki injunan caca na lantarki ('Terminals na Fare na Fixed Odds') don wakiltar nau'in caca mai matsala; sauran ukun an ɗauke su a matsayin yin fare na wasanni (akan dawaki), wasan karta na intanet / blackjack, da wasannin gidan caca (roulette) a matsayin mafi matsala. A kan ƙimar mafi girman adadin kuɗin da aka yi caca a rana ɗaya, biyar sun amince da kwandon £1,000-£10,000, kuma huɗu sun amince da sama da £10,000. Lokacin da aka yi musu tambaya game da basussukan da suka shafi caca, ɗaya daga cikin masu caca ya ƙi bayar da bayanan bashi, ɗaya daga cikin masu caca ya ba da rahoton babu bashi saboda amfani da tanadi na mutum, kuma bashin da ake bin sa a yanzu a cikin sauran bakwai ya kama daga £4000-£35,000 (matsakaicin £15,714).

Mahalarta sun kammala sikelin ɗabi'un da suka shafi UPPS-P ( Cyders et al., 2007 ), tambayoyi na kai-tsaye guda 59 tare da ƙananan ma'auni guda biyar waɗanda ke tantance gaggawar da ba ta dace ba (misali "Wani lokaci idan na ji ba daɗi, ba zan iya dakatar da abin da nake yi ba duk da cewa yana sa ni jin muni"), gaggawar da ta dace (misali "Lokacin da na yi farin ciki, ina jin kamar ba zan iya hana kaina yin abin da ya wuce gona da iri ba"), (rashin) Tsara (misali "Yawancin lokaci ina yanke shawara ta hanyar tunani mai kyau" - lodi mara kyau), (rashin) Juriya (misali "Na gama abin da na fara" - lodi mara kyau) da Neman Jin Daɗi (misali "Zan ji daɗin jin daɗin yin tsere a kan dusar ƙanƙara da sauri a kan babban gangaren dutse"). Ba mu sami damar samun bayanan UPPS-P daga ɗaya daga cikin masu sa kai na sarrafa bayanai ba.

Sayo hoto da sarrafawa

An samo duk hotunan PET ta amfani da na'urar daukar hoton ECAT HR + 962 (CTI/Seimens) tare da filin hangen nesa na axial na 15.5 cm. [11C]-raclopride an yi shi azaman allurar bolus ta jijiya ga masu sa kai na PG, kuma ga masu sa kai na kulawa a matsayin bolus ta jijiya ta farko sannan aka biyo baya da jiko akai-akai, tare da tsawon jiko na mintuna 85 don yin gwaji huɗu daga binciken Egerton et al. (2010) da mintuna 100 don yin gwaji biyar daga binciken Stokes et al. (2010) . An yi gwajin watsawa na mintuna 10 kafin kowane gwajin fitar da hayaki don aunawa da gyara don rage nama. An sami hotunan fitar da hayaki masu ƙarfi a cikin yanayin girma uku ta amfani da ƙa'idar siye ta yau da kullun (tsarin lokaci 20 akan mintuna 60 ga mahalarta PG, tsarin lokaci 28 akan mintuna 85 don yin gwaji na Egerton et al. (2010) da tsarin firam 38 akan mintuna 100 don yin gwaji na Stokes et al. (2010) ). Ga mahalarta PG, hoton da suka ɗauka ya ƙunshi gabatar da hotuna marasa tsari, waɗanda suka haɗa da yanayin ƙasa, abubuwan gida da kuma tsarin bazuwar, amma ba tare da buƙatar injin ba (an duba mahalarta sau ɗaya kawai).

An gyara duk wani na'urar daukar hoto mai motsi don motsa kai ta amfani da tsarin daidaitawa na firam (FBF) ( Montgomery et al., 2006 ). An yi amfani da wannan hanyar a duk firam ɗin don samar da hoton motsi mai motsi wanda FBF ya gyara, wanda daga nan aka yi nazari a kai ta amfani da nazarin yanki mai amfani da kansa (ROI), wanda aka ƙara masa da nazarin voxelwise mai tabbatarwa.

Nazarin ROI

An bayyana ROIs na Striatal da cerebellar ta amfani da atlas wanda ya ƙunshi sassa uku na aiki na striatum; limbic, associative da sensorimotor striatum, da kuma cerebellum a matsayin yankin tunani. Rarrabuwar striatal suna kama da ventral striatum (limbic striatum), pre-commissural dorsal putamen, pre-commissural dorsal caudate da post-commissural dorsal caudate (associative striatum) da post-commissural putamen (sensorimotor striatum) ( Martinz et al., 2003 ). An canza samfurin [11C]-raclopride a sarari zuwa sararin PET na kowane hoton ƙara da aka gyara na FBF (wanda aka samar daga kowane hoto mai ƙarfi da aka gyara na FBF ta amfani da software na cikin gida da aka rubuta a Matlab (sigar 5; The MathWorks, Inc, Natick, Mass)) a cikin SPM5 ( www.fil.ion.ucl.ac.uk/spm ) kuma an yi amfani da matrix na nakasassu da ya haifar a cikin atlas ɗin. An yi amfani da atlas ɗin striatal mai nakasa don yin samfurin ƙidaya daga hotunan dynamic [11C]-raclopride don duban PG, kuma daga yanayin da aka daidaita mai nauyi ƙara hoto don duban sarrafawa, ta amfani da software na Analyze 8.0 ( www.analyzedirect.com ). Don duban PG, ƙimar [11C]-raclopride BP ND , rabon radioligand da aka ɗaure musamman zuwa na ligand mara canzawa a cikin ƙwayar ma'anar cerebellar ( Innis et al., 2007 ), an ƙididdige ta ta amfani da samfurin nama mai sauƙi tare da cerebellum azaman nama na tunani ta amfani da software na cikin gida da aka rubuta a Matlab. Don duban sarrafawa, an ƙididdige ƙimar [11C]-raclopride BP ND azaman rabo na ƙidayar striatal zuwa ƙidayar cerebellar, ban da 1, a cikin lokacin yanayin da aka daidaita. An bayyana lokacin da aka ɗauka don gwajin jiko na bolus a matsayin farawa daga mintuna 39 bayan allurar kuma ci gaba har zuwa ƙarshen gwajin, bisa ga kimantawa na lokacin da ya fi dacewa don kafa yanayin da aka ɗauka ( Watabe et al., 2000 ).

Nazarin Voxelwise

Don sikanin aikin agaji na PG, an samar da hotunan [11C] -raclopride na asali daga hotunan tsayayyen mutum ta hanyar amfani da samfurin nama mai sauki wanda aka sanya tare da cerebellum a matsayin kayan ishara da ake amfani dasu a cikin kayan aikin gidan da aka rubuta a cikin Matlab. Don yin sikanin agaji na sarrafawa, an samar da hotunan abubuwa daga yanayin daidaitaccen mutum wanda ya kara hotuna ta amfani da algebra a cikin SPM5 ta hanyar kirga kirgawa ga kowane voxel tare da kirga kirim da kuma rage daya. Duk hotuna masu sifa sai aka daidaita su zuwa [11C] -raclopride PET samfuri ta amfani da matrix nakasawa ta hanyar canjin sararin samaniya na mutum ya ƙara hotuna zuwa samfurin. An daidaita hotunan al'ada na al'ada a cikin SPM5 ta amfani da kwaya mai santsi 6 mm.

Nazarin lissafi

An tantance bambance-bambancen rukuni a cikin sha'awar sha'awa da ƙimar BP ND ta yanki ta amfani da nazarin bambance-bambancen multivariate (MANOVA), wanda aka aiwatar a cikin SPSS 15 (SPSS, Chicago, Illinois). An tantance alaƙar da ke tsakanin ƙimar gaggawa da BP ND ta amfani da ma'aunin haɗin kai na ɓangare, suna sarrafa shekaru idan aka yi la'akari da ƙarfin tasirin shekaru akan ma'aunin PET na samuwar masu karɓar D 2 /D 3 ko da a cikin matsakaicin girma ( Backman et al., 2000; Kim et al., 2011 ). An aiwatar da matakin ƙididdiga na Bonferroni na p < .00625 don nazarin haɗin gwiwa, yana daidaitawa ga yankuna huɗu na tashin hankali (gabaɗaya, limbic, associative, sensorimotor) da sikelin gaggawa guda biyu. Don nazarin voxelwise, an bincika alaƙa tsakanin haɗin gaggawa da [11C]-raclopride ta amfani da nazarin komawa baya da yawa a cikin SPM5, wanda aka iyakance ga striatum, kuma an sake haɗa da shekarun sa kai azaman covariate. An yi amfani da matakin matakin rukuni da aka gyara na p < 0.05 tare da girman rukuni fiye da voxels goma don mahimmancin ƙididdiga.

Ka tafi zuwa ga:

results

A kan sikelin UPPS-P, akwai babban tasirin rukuni (lambda na Wilks = 0.21, F(5,11) = 8.44, p = .002) tare da ƙungiyar PG ta sami maki mafi girma fiye da na lafiya akan Gaggawa mara kyau (F 1,15 = 43.0, p < .001), Gaggawa Mai Kyau (F 1,15 = 17.4, p = .001), da (rashin) Tsarin (F 1,15 = 4.95, p = .042). Daidai da rahotonmu na baya-bayan nan a cikin wani rukunin PG da aka ɗauka ta hanyar asibiti ɗaya ( Michalczuk et al., 2011 ), girman tasirin ya fi girma akan ƙananan ma'auni guda biyu na Gaggawa (duba Tebur 1 ). Babu wani bambanci mai mahimmanci tsakanin ƙungiyoyi akan (rashin) Juriya (F 1,15 = 0.59, p = .455) da Neman Jin Daɗi (F 1,15 = 0.76, p = .398).

Table 1

Tebur 1

Ƙarfin ɗaurewar mai karɓar dopamine D2/3 na Striatal da ɓangarorin sha'awa a cikin Masu Caca da Lafiya, tare da rahoton girman tasirin kamar Cohen's d.

Nazarin ROI

Babu wani bambanci na rukuni gaba ɗaya a cikin ƙimar ND [11C]-raclopride BP (lambda na Wilks = 0.59, F(4,13) = 2.22, p = .124), ba tare da wani bambanci a cikin jimlar striatum ba (F 1,16 = 0.22, p = .64) ko a cikin kowane ɓangare uku na striatal (limbic F 1,16 = 0.02, p = 0.879; associative F 1,16 = 0.54, p = 0.473; sensorimotor F 1,16 = 0.05, p = .819) (duba Hoto na 1 da Tebur 1 ).

Siffa 1

Siffa 1

[11C]-raclopride binding potentials (BP ND ) don yankin striatum gabaɗaya mai sha'awa (biyu) da kuma limbic subside, ga shari'o'in mutum ɗaya tare da Pathological Caca da kuma kula da lafiya.

A cikin rukunin PG, an lura da daidaitawa mara kyau (partialling for age) tsakanin Negative gaggawa da [11C] -raclopride BPND dabi'u a cikin jimlar tashin hankali (Siffa 2A), da kuma limbic da sassan tarayya na maɓallin, kowannensu yana da mahimmanci a matakin Bonferroni-gyara (duba) Tebur 2). Tabbatacce gaggawa ya kasance tare da mummunar dangantaka da BPND dabi'u a cikin jimlar tashin hankali (Siffa 2B), da kuma tsarin hadin kai, a bakin kofar da aka gyara. Rikicin gaggawa da itivearfafawa na gaggawa sun kasance da kansu a ɗan daidaita-daidaitacce (57% bambancin raba a cikin PG, 81% bambancin raba a cikin sarrafawa). Dangantaka tsakanin gaggawa da BPND ba a bayyane ya bayyana kasancewar masu shan sigari huɗu a cikin rukunin PG ba: masu shan sigari (tare da PG waɗanda ba masu shan sigari ba) sun nuna bambance-bambance marasa kyau a cikin Gaggawar Gaggawa (Mutuwar Gaggawa na nufin = 39.0 vs 38.4; Ingantaccen Gaggawa yana nufin = 38.8 vs 37.0) da BPND dabi'u (limbic striatum yana nufin = 2.20 vs 2.24). Ba tare da shekaru an haɗa shi azaman mai saurin canzawa ba, BPND remaineda'idoji sun kasance muhimmi ga Urarfin gaggawa (janar r9 = −.875, p = .002; limbic r9 = −.846, p = .004; shirki r9 = -.868, p = .002) amma daidaito kan Ingantaccen gaggawa bai sami mahimmanci a ƙofar da aka gyara ba (gaba ɗaya r9 = −.703, p = .035; shirki r9 = −.738, p = .023). Yawancin lambobi akan Matsalar Matsalar Caca (PGSI) an haɗa su da BPND dabi'u a cikin mahaɗan mahaɗan (m rho = -.881, p = .004) amma ba su da mahimmanci ba tare da shekaru sun haɗa su azaman mai canji ba (r9 > - 0.45, p> 0.22). PGSI yana da alaƙa sosai da Ingantaccen Gaggawa (r9 = .916, p <.001) amma ba mahimmanci ba tare da Gaggawar Gaggawa (r9 = .627, p = .071).

Siffa 2

Siffa 2

Alaƙa tsakanin Masu Caca da Cututtuka tsakanin [11C]-raclopride BP ND a cikin yanayin damuwa na gaba ɗaya da UPPS-P Gaggawa mara kyau (A) da Gaggawa Mai Kyau (B). C: Dangantaka mai kusurwa huɗu tsakanin [11C]-raclopride BP ND a cikin yanayin damuwa na limbic da Gaggawa mara kyau a cikin yanayin damuwa na …

Table 2

Tebur 2

Haɗin gwiwa na ɓangare (wanda ke sarrafa shekaru) a cikin Masu Caca na Pathological tsakanin [11C]-raclopride BP ND a cikin yankunan da ke da sha'awa da gaggawa (Negative, Positive). Ƙimar da aka rubuta da madauri sun kasance masu mahimmanci a kididdiga bayan Bonferroni …

Ƙimar BP ND ba ta da alaƙa sosai da ma'aunin gaggawa a cikin ƙungiyar kulawa (r = − 0.36 zuwa 0.31, p > 0.42). Hakika, ga dangantakar da ke tsakanin gaggawar rashin kyau da BP ND a cikin limbic striatum, gwajin kai tsaye na bambanci tsakanin masu haɗin gwiwa na haɗin gwiwa ya tabbatar da dangantaka mai ƙarfi a cikin ƙungiyar PG idan aka kwatanta da masu sarrafawa (canjin Fisher's r zuwa z; z = 2.03, p = .043), kodayake gwaje-gwaje iri ɗaya a cikin jimlar yanayin gaggawar rashin kyau (z = 1.48, p = .139) da gaggawar tabbatacce (z = 0.97, p = .332) ba su da mahimmanci. Ganin yadda ƙungiyar ke ƙaruwa a cikin sha'awar yanayi a cikin ƙungiyar PG, mun kuma gudanar da wani bincike bayan-hoc don gwada dangantakar quadratic tsakanin gaggawa da [11C]-raclopride BP ND a cikin samfurin da aka tattara, dangane da rahoton da aka bayar kwanan nan game da dangantakar 'inverted U' tsakanin ɗaurewar ventral striatal raclopride da kuma neman halaye a cikin masu sa kai masu lafiya ( Gjedde et al., 2010 ). A cikin komawa ga ƙimar ɗaurewar [11C]-raclopride a cikin limbic striatum (mai dogara) zuwa Negative Urgency (mai hasashen yanayi), samfurin gabaɗaya bai kai ga mahimmanci ba (F(2,14) = 3.65, p = .053) amma akwai babban tasiri na kalmar quadratic (β = − 4.07, t = − 2.21, p = .045) ( Hoto na 2 C). Ba a lura da waɗannan tasirin quadratic ba don Ingantaccen Gaggawa a cikin limbic striatum (β = − 2.30, t = − 1.40, p = .183), ko kuma a cikin striatum gabaɗaya (Gaggawa mara kyau: β = − 3.10, t = − 1.56, p = .141; Kyakkyawan Gaggawa: β = − 1.75, t = − 1.06, p = .306). Ƙoƙarin kai tsaye na kwafi tasirin quadratic don Sensation Search a cikin limbic striatum shi ma ba shi da mahimmanci (β = 1.35, t = 0.44, p = .664).

Nazarin Voxelwise

Kwatanta ƙungiyar voxelwise ba ta tabbatar da wani bambanci mai mahimmanci a cikin ɗaurewar [11C]-raclopride tsakanin PG da sarrafawa ba. Juyawar voxelwise akan gaggawa mara kyau a cikin ƙungiyar PG ta tabbatar da alaƙar da ke tsakaninta da ɗaurewar [11C]-raclopride a cikin abubuwan haɗin gwiwa biyu waɗanda suka tashi daga ventral putamen zuwa kan caudate a dama (haɗin gwiwa mafi girma: x = 10, y = 17, z = − 5, girman gungu = 227, p < 0.001 an gyara gungu) da jikin caudate na hagu (haɗin gwiwa mafi girma: x = − 10, y = 13, z = 2, girman gungu = 103, p = 0.001 an gyara gungu). Juyawar da aka yi wa Positive Urgency ta haifar da haɗin gwiwa na biyu wanda ya tashi daga ƙwayoyin halittar tsakiya da kuma ventral putamen har zuwa jikin caudate a dama (matsakaicin kololuwa: x = 21, y = 15, z = − 5, girman rukuni = 409, p < An gyara rukuni 0.001) da kuma caudate na hagu da putamen (matsakaicin kololuwa: x = − 25, y = 13, z = − 2, girman rukuni = 297, p < An gyara rukuni 0.001) (duba Hoto na 3 ). Don tantance takamaiman waɗannan alaƙar da ke da alaƙa da rashin sha'awar yanayi, mun kuma shigar da (rashin) Tsarin a matsayin mai hasashen ɗaurewar [11C]-raclopride; ba a gano voxels na sama-ƙasa ba.

Siffa 3

Siffa 3

Sakamakon koma-baya na [11C]-raclopride BP ND a cikin Masu Caca ta Pathological, yana nuna mummunan alaƙa da Gaggawa mara kyau (A) (y = +15, z = − 5) da Gaggawa Mai Kyau (B) (y = +15, …

Ka tafi zuwa ga:

tattaunawa

Ba mu gano wani bambanci ba a cikin samuwar dopamine D2/D3 mai karɓar striatal tsakanin maza masu halartar sabis na musamman na magani, da kuma kula da lafiyayyen maza masu shekaru. Baya ga ƙididdige samuwar mai karɓar D2/D3 mai karɓar striatal gabaɗaya , binciken ROI ya kuma bincika samuwar mai karɓar a cikin sassa uku na aiki na striatum. Rarrabawar limbic ta ƙunshi nucleus accumbens, ventral putamen da ventral caudate, kuma ana danganta ta sosai da cututtukan jaraba ciki har da caca mara kyau ( Linnet et al., 2011; O'Sullivan et al., 2011; Steeves et al., 2009 ). Lura da muka yi game da babu wani bambanci a cikin samuwar mai karɓar dopamine D2/D3 na asali tsakanin mahalarta PG da masu sarrafawa ya yi daidai da binciken [11C]-raclopride guda biyu da suka yi kwanan nan waɗanda suka kimanta canjin ɗaurewa yayin da waɗanda ke cikin PG suka yi ayyuka daban-daban na yanke shawara / caca ( Joutsa et al., 2012; Linnet et al., 2011 ), da kuma wani bincike na PET na uku da aka kwatanta marasa lafiya da ke fama da cutar Parkinson tare da kuma ba tare da rikice-rikicen sarrafa sha'awa ba, gami da PG, yayin kallon hotuna masu alaƙa da lada ( O'Sullivan et al., 2011 ). Ba mu iya tabbatar da raguwar ƙimar BP ND da Steeves et al (2009) suka ruwaito a cikin shari'o'i 7 da ke fama da cutar Parkinson, tare da PG da dopamine-agonist ya haifar. Ya kamata a lura cewa binciken farko sun haɗa da zaɓin motsi (zaɓin layi tsakanin katunan kati guda huɗu tare da ra'ayoyi marasa ma'ana), wanda zai iya karkatar da kimantawar samuwar tushe ( Egerton et al., 2009 ).

Za a iya samun wasu ƙididdiga da dama daga bincikenmu a cikin PG. Da farko, raguwar samuwar masu karɓar dopamine D 2 /D 3 da aka bayyana a baya a cikin masu amfani da sinadarai ( Fehr et al., 2008; Heinz et al., 2004; Martinez et al., 2004; Volkow et al., 1997, 2001 ) na iya faruwa ne ta hanyar halayen neuroadaptive ko neurotoxic na magungunan da kansu, kuma ba su dace da raunin da ke tattare da cutar jaraba ba. Daidai da wannan bayanin, samuwar masu karɓar D 2 yana da alaƙa mara kyau da tsawon lokacin cin zarafin mai motsa jiki a cikin samfurin gwaji na primate ( Nader et al., 2006 ). Wata fassarar madadin ita ce raguwar ɗaure dopamine na iya wakiltar haɗarin jarabar miyagun ƙwayoyi wanda ba ya haɗa da PG a matsayin jarabar ɗabi'a. An bayar da rahoton raguwar samuwar masu karɓar dopamine a cikin kiba ( Wang et al., 2001 ), a matsayin wani jarabar ɗabi'a na ɗan takara. Ba shakka, bincikenmu ba zai hana yiwuwar canje-canje ga sauran tsarin neurotransmitter a cikin PG ba, kamar glutamate, GABA ko serotonin ( Leeman da Potenza, 2012 ), ko kuma canje-canje a wasu fannoni na watsa dopamine kamar saki ( Linnet et al., 2011 ), sake dawowa ( Cilia et al., 2010 ) ko metabolism ( Bergh et al., 1997 ). Wani ra'ayi na biyu daga bincikenmu shine cewa duk wani sakin dopamine da aka haifar ta hanyar jadawalin cin nasara da rashin nasara da masu caca ke fuskanta (misali Zald et al., 2004 ) bazai isa ya rage yawan samuwar masu karɓar D 2 / D 3 ba.

Duk da haka, a cikin ƙungiyar masu caca, ɗaurewar [11C]-raclopride yana da alaƙa mara kyau da rashin sha'awa, wani abu mai haɗari da aka kafa don matsalar caca ( Slutske et al., 2005 ) da rikice-rikicen amfani da miyagun ƙwayoyi ( Ersche et al., 2010 ). Bangaren sha'awa da muka gano a matsayin hasashen ɗaurewar dopamine mai sha'awa shine Gaggawa (ko 'rashin sha'awa mai sauri'), yanayin aikata ayyukan sha'awa a ƙarƙashin yanayin yanayi mai tsanani. Kwatancen kula da shari'a akan ɓangaren Gaggawa ya haifar da girman sakamako mafi ƙarfi fiye da 'ƙarancin sha'awa' (watau rashin shiri, rashin juriya), wanda aka gani a cikin babban rukuni da aka ɗauka daga yanayin asibiti ɗaya ( Michalczuk et al., 2011 ). Rashin ƙaramin tsari bai annabta ɗaurewar dopamine mai sha'awa ba a cikin nazarin voxelwise. Sakamakon gaggawa yana annabta sauye-sauye zuwa caca mai matsala, shan muggan kwayoyi da sauran halaye masu haɗari a cikin samfuran kwaleji ( Cyders da Smith, 2008 ). Ba a san komai game da tsarin kwakwalwa wanda ke daidaita wannan takamaiman ɓangaren na sha'awar jima'i ba, kodayake wani bincike na magnetic resonance spectroscopy na baya-bayan nan ya ba da rahoton alaƙar gaggawa da matakan GABA a cikin cortex na gaba na dorsolateral ( Boy et al., 2011 ), kuma bayanan beraye sun nuna daidaita matakan dopamine na striatal ta hanyar GABA na cortical ( Matsumoto et al., 2005 ). A cikin ƙungiyar PG, ɓangarorin mara kyau da na kyau na gaggawa sun annabta samuwar mai karɓar dopamine D 2 / D 3 na striatal . An ga waɗannan alaƙar a cikin sassan striatal ROI gabaɗaya da kuma sassan limbic (Negative Urgency) da haɗin gwiwa (duka Negative and Positive Urgency), kuma an tabbatar da su a cikin nazarin voxelwise. Sakamakon gaggawa mara kyau da na positive sun kasance suna da alaƙa da juna, kodayake har yanzu ba a san ko marasa lafiya da ke da PG suna da rauni iri ɗaya ga abubuwan da ke haifar da motsin rai (misali euphoria) da kuma abubuwan da ke haifar da motsin rai mara kyau (misali gundura, baƙin ciki) ba ( Blaszczynski da Nower, 2002; Stewart da Zack, 2008 ).

Alaƙar da ke tsakanin Gaggawa da samuwar masu karɓar dopamine ba ta bayyana ba a cikin ƙaramin rukuni na masu sarrafa lafiya da aka gwada a nan. Hakika, ma'aunin Gaggawa Mai Kyau a cikin limbic striatum ya fi ƙarfi a cikin ƙungiyar PG fiye da masu sarrafawa. A cikin mutanen da ke da dogaro da methamphetamine, kasancewar masu karɓar D 2 /D 3 striatal shi ma yana da alaƙa da rashin ƙarfin hali ( Lee et al., 2009 ). Dangane da wani rahoto na baya-bayan nan a cikin mahalarta masu lafiya wanda ya nuna alaƙar quadratic tsakanin ɗaurewar ventral striatal [11C]-raclopride da kuma neman Sensation ( Gjedde et al., 2010 ), mun yi wani bincike na bayan-hoc don gwada irin wannan tasirin Gaggawa Mai Kyau a cikin samfurin PG ɗinmu da aka tattara da kuma masu sarrafa lafiya. Mun kwafi tasirin 'inverted U' (ko Yerkes-Dodson) a cikin limbic striatum, a matsayin aikin Gaggawa Mai Kyau. Wannan yana nuna cewa duka matakan girma da ƙananan na rashin ƙarfin hali suna da alaƙa da ɗaurewar raclopride mai ƙarancin ƙarfi, kuma BP ND shine mafi girma a tsakiyar kewayon rarrabawa.

A ka'ida, raguwar BP ND na iya nuna raguwar bayyanar masu karɓar dopamine na D2 / D3 da /ko ƙaruwa a matakan dopamine na synaptic. Wani bincike da aka yi amfani da alpha-methyl paratyrosine (AMPT) don rage dopamine a cikin waɗanda suka dogara da cocaine ya nuna raguwar samuwar masu karɓar tare da raguwar matakan dopamine na extracellular a ƙarƙashin yanayin tushe ( Martinez et al., 2009 ). Duk da haka, aikin farko a cikin PG ya nuna ƙaruwar sakin dopamine da ke da alaƙa da aiki a cikin wani ɓangare na mahalarta PG waɗanda suka ba da rahoton farin ciki da ya shafi aiki ( Linnet et al., 2011 ). Ana iya tunanin cewa ƙarancin BP ND a cikin ƙananan bugun zuciya na iya haifar da raguwar samuwar masu karɓar D2/D3, yayin da ƙarancin BP ND a cikin manyan bugun zuciya na iya haifar da raguwar samuwar masu karɓar da haɓakar dopamine na extracellular ( Gjedde et al., 2010 ). Ƙara yawan sakin dopamine kuma yana iya alaƙa da raguwar tsarin (midbrain) autoreceptor, kamar yadda aka gano tare da [18F]-fallypride ligand ( Buckholtz et al., 2010 ). A cikin wannan bayanan, an yi taka tsantsan saboda gaskiyar cewa kalmar quadratic ta samo asali ne daga mahalarta PG da suka faɗi a hannun dama, ƙasa, tare da bambancin halaye da aka bayyana a cikin wannan rukunin. Don fayyace waɗannan alaƙar, ana buƙatar ƙarin bincike ta amfani da alamomi da yawa na aikin dopamine a cikin cikakken kewayon halayen motsa jiki, amma za mu ba da shawarar cewa nazarin nan gaba ya yi la'akari da bambance-bambancen mutum ɗaya na layi da na huɗu a cikin hanyar dopamine.

Ganin cewa ƙarin iyakokin wannan binciken, girman rukuninmu ƙanana ne, don haka binciken bai sami isasshen ƙarfin gano ƙananan girman tasirin ba. Dangane da girman tasirin ga jimlar tasirin (Cohen's d = 0.22), za a buƙaci ƙungiyoyi biyu na akalla mahalarta 350 don gano bambanci mai mahimmanci a kididdiga. Na biyu, amfani da ingantattun iko daga bayanan bayanai na yau da kullun ya sanya wasu ƙananan bambance-bambancen tsari tsakanin ƙungiyoyin biyu: an gabatar da mutanen PG da hotuna masu tsaka-tsaki yayin binciken su (kodayake ba tare da buƙatar amsawa ba), kuma mutanen PG sun sami allurar bolus yayin da masu sarrafawa suka sami allurar bolus da jiko. Aikin da ya gabata ya nuna cewa ƙimar ɗaure [11 C]-raclopride da aka samar ta hanyar hanyar bolus kawai kusan iri ɗaya ne da ƙimar ɗaure da aka samar ta hanyar hanyar bolus-infusion a cikin masu sa kai ɗaya ( Carson et al., 1997; Ito et al., 1998 ). A cikin mahalarta PG, akwai wani matakin bambancin lokaci a lokacin binciken dangane da magani (yawanci amma ba duka aka duba kafin magani ba), kuma akwai cututtukan tabin hankali a cikin mahalarta huɗu. Binciken da aka yi bayan tiyata ya nuna cewa tasirinmu bai danganta da matsayin shan taba ba ( Busto et al., 2009 ; cf Fehr et al., 2008 ). Matsalolin tabin hankali ba shakka sun fi yawa a cikin PG ( Kessler et al., 2008 ) kuma haɗa irin waɗannan shari'o'in yana ƙara yawan bincikenmu.

Dangane da amfani da asibiti, abin lura ne cewa yayin da pramipexole mai maganin dopamine da aripiprazole mai maganin ɓacin rai suka kasance suna da hannu a cikin fara caca mara kyau ( Smith et al., 2011; Voon et al., 2009 ), masu adawa da masu karɓar dopamine D2 kamar olanzapine har yanzu ba su nuna cikakken tasiri a cikin gwaje-gwajen maganin PG ba ( Fong et al., 2008; McElroy et al., 2008 ). A cikin ƙungiyoyin mahalarta masu lafiya, samuwar dopamine na asali yana shafar aikin wakilan dopaminergic daidai da tsarin U mai juyawa ( Cools da D'Esposito, 2011 ), don haka bincikenmu na bambancin ra'ayi a cikin rashin daidaituwar dopamine a cikin caca mara kyau yana nuna cewa mutanen da ke da babban sha'awar yanayi na iya nuna fa'idodi daban-daban daga magungunan da ke tushen dopamine. Misali, idan ƙarancin ɗaurewar [11 C]-raclopride a cikin masu caca masu yawan motsa jiki ya samo asali ne daga ƙaruwar dopamine na synaptic ( Gjedde et al., 2010 ), waɗannan mutane na iya mayar da martani ga toshewar dopamine. Alaƙar quadratic tare da bambance-bambancen mutum ɗaya tabbas yana nuna cewa hanyoyin dopamine da yawa na iya aiki a cikin cututtukan jaraba ( Buckholtz et al., 2010; Cilia et al., 2010; Gjedde et al., 2010 ).

Ka tafi zuwa ga:

Sanarwa

L Clark ya ba da sanarwar tuntuba ga kamfanin Cambridge Cognition plc. AR Lingford-Hughes ya karɓi girmamawa daga Janssen-Cilag, Pfizer, Servier, da kuma daga Britishungiyar Burtaniya ta Psychopharmacology. Ta ba da shawara ga NET Device Corp, ta karɓi tallafin bincike daga Archimedes, Lundbeck, Pfizer da Schering, kuma ta riƙe tallafin bincike tare da GlaxoSmithKline. DJ Nutt ya yi aiki a kan kwamitocin shawarwari na Lundbeck, Servier, Pfizer, Reckitt Benkiser, D&A Pharma, kuma ya karɓi girmamawa daga Bristol Myers Squibb, Glaxo Smith Kline da Schering-Plow. Ya karɓi kuɗin bincike daga P1vital, yana da zaɓuɓɓukan raba tare da P1vital, kuma yana karɓar girmamawar edita daga Sage. AR Lingford-Hughes da DJ Nutt duka mambobi ne na Lundbeck International Neuroscience Foundation. Dokta Stokes, Dr Wu, Ms Michalczuk, Ms Benecke, Dr Egerton, Dr Watson, Dr Piccini da Dr Bowden-Jones ba su da wata sha'awar kudi da za su bayyana.

Ka tafi zuwa ga:

Acknowledgments

An tallafawa wannan aikin ta hanyar Binciken Binciken Lafiya na G0802725 zuwa LC da HBJ, da G0400575 ga DJN da ALH. Asusun caca na Matsalar isasa yana da goyan bayan Asusun caca mai alhakin. An kammala aikin a cikin Cibiyar Nazarin Behavioral da Clinical Neuroscience, ta hanyar tallafin haɗin gwiwa daga MRC da Wellcome Trust (darekta: TW Robbins). An gabatar da bayanan a theungiyar forungiyar Burtaniya don haɗuwa da lokacin bazara, Harrogate, UK (Yuli 2011).

Ka tafi zuwa ga:

References

Backman L., Ginovart N., Dixon RA, Wahlin TB, Wahlin A., Halldin C., Farde L. Rashin fahimtar juna da suka shafi shekaru wanda canje-canje a cikin tsarin dopamine na striatal ke haifarwa. Am. J. Psychiatry. 2000;157:635–637. [ PubMed ]

Bergh C., Eklund T., Sodersten P., Nordin C. Canjin aikin dopamine a cikin caca ta hanyar cututtuka. Psychol. Med. 1997;27:473–475. [ PubMed ]

Blaszczynski A., Nower L. Tsarin hanyoyin magance matsalar caca da kuma matsalar cututtuka. Jaraba. 2002;97:487–499. [ PubMed ]

Bowden-Jones H., Clark L. Caca ta Pathological: sabuntawar jijiyoyi da asibiti. Br. J. Psychiatry. 2011;199:87–89. [ PubMed ]

Boy F., Evans CJ, Edden RA, Lawrence AD, Singh KD, Husain M., Sumner P. Dorsolateral prefrontal gamma-aminobutyric acid a cikin maza yana annabta bambance-bambancen mutum ɗaya a cikin rashin saurin amsawa ga kurji. Biol. Psychiatry. 2011;70:866–872. [ PubMed ]

Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R., Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Kessler RM, Zald DH Bambancin hanyar sadarwa na Dopaminergic a cikin sha'awar ɗan adam. Kimiyya. 2010;329:532. [ PubMed ]

Busto UE, Redden L., Mayberg H., Kapur S., Houle S., Zawertailo LA Ayyukan dopaminergic a cikin masu shan taba masu baƙin ciki: nazarin hotunan positron emission. Synapse. 2009;63:681–689. [ PubMed ]

Carson RE, Breier A., ​​de Bartolomeis A., Saunders RC, Su TP, Schmall B., Der MG, Pickar D., Eckelman WC Ƙididdige canje-canjen da amphetamine ke haifarwa a cikin ɗaurewar [11C]raclopride tare da ci gaba da jiko. J. Cereb. Blood Flow Metab. 1997;17:437–447. [ PubMed ]

Chase HW, Clark L. Tsananin caca yana annabta martanin kwakwalwa ga sakamakon da ba a samu ba. J. Neurosci. 2010;30:6180–6187. [ PubMed ]

Cilia R., Ko JH, Cho SS, van Eimeren T., Marotta G., Pellecchia G., Pezzoli G., Antonini A., Strafella AP Rage yawan masu jigilar dopamine a cikin yanayin ventral na marasa lafiya da ke fama da cutar Parkinson da kuma caca ta hanyar cututtuka. Neurobiol. Dis. 2010;39:98–104. [ PubMed ]

Cools R., D'Esposito M. Ayyukan dopamine masu siffar U da aka juye akan ƙwaƙwalwar aiki ta ɗan adam da kuma ikon fahimtar mutum. Biol. Psychiatry. 2011;69:e113–e125. [ PubMed ]

Cyders MA, Smith GT Halayen motsin rai ga gaggawa: gaggawa mai kyau da mara kyau. Psychol. Bull. 2008;134:807–828. [ PubMed ]

Cyders MA, Smith GT, Spillane NS, Fischer S., Annus AM, Peterson C. Haɗakar sha'awa da yanayi mai kyau don annabta halaye masu haɗari: haɓakawa da tabbatar da ma'aunin gaggawa mai kyau. Psychol. Kimanta. 2007;19:107–118. [ PubMed ]

Dalley JW, Fryer TD, Brichard L., Robinson ES, Theobald DE, Laane K., Pena Y., Murphy ER, Shah Y., Probst K., Abakumova I., Aigbirhio FI, Richards HK, Hong Y., Baron JC, Everitt BJ, Robbins TW Masu karɓar Nucleus accumbens D2/3 suna annabta sha'awar halaye da ƙarfafa cocaine. Kimiyya. 2007;315:1267–1270. [ PubMed ]

Di Chiara G., Imperato A. Magungunan da mutane ke amfani da su suna ƙara yawan sinadarin synaptic dopamine a cikin tsarin mesolimbic na beraye masu motsi cikin 'yanci. Proc. Natl. Acad. Sci. Amurka 1988;85:5274–5278. [ PubMed ]

Egerton A., Mehta MA, Montgomery AJ, Lappin JM, Howes OD, Reeves SJ, Cunningham VJ, Grasby PM Tushen dopaminergic na halayen ɗan adam: bita na nazarin hotunan kwayoyin halitta. Neurosci. Biobehav. Rev. 2009;33:1109–1132. [ PubMed ]

Egerton A., Shotbolt JP, Stokes PR, Hirani E., Ahmad R., Lappin JM, Reeves SJ, Mehta MA, Howes OD, Grasby PM Tasirin maganin hana shan kwayoyi na bupropion akan yawan dopamine na waje a cikin yanayin ɗan adam: nazarin PET na [11C]raclopride. Neuroimage. 2010;50:260–266. [ PubMed ]

Ersche KD, Turton AJ, Pradhan S., Bullmore ET, Robbins TW Endophenotypes na jarabar miyagun ƙwayoyi: halayen halayen da ke neman sha'awa da sha'awa. Biol. Psychiatry. 2010;68:770–773. [ PubMed ]

Fehr C., Yakushev I., Hohmann N., Buchholz HG. samuwa tare da dogaro da nicotine kwatankwacin wanda aka gani tare da sauran magungunan zagi. Am. J. Likitan tabin hankali. 2008; 165:507–514. [ PubMed ]

Ferris J., Cibiyar Kanada ta Wynne H. akan Zagi; Ottawa, Ontario: 2001. Index na amblingungiyar Caca Caca.

Fong T., Kalechstein A., Bernhard B., Rosenthal R., Rugle L. Gwaji mai kama da olanzapine mai makanta biyu, wanda aka sarrafa shi ta hanyar placebo don magance masu caca na wasan poker na bidiyo. Pharmacol. Biochem. Behav. 2008;89:298–303. [ PubMed ]

Frascella J., Potenza MN, Brown LL, Childress AR Rarraba raunin kwakwalwa yana buɗe hanya ga jarabar da ba ta da sinadarai: jarabar sassaka a sabon haɗin gwiwa? Ann. NY Acad. Sci. 2010;1187:294–315. [ PubMed ]

Gjedde A., Kumakura Y., Cumming P., Linnet J., Moller A. Alaƙa mai siffar U tsakanin samuwar masu karɓar dopamine a cikin striatum da kuma neman jin daɗi. Proc. Natl. Acad. Sci. Amurka 2010;107:3870–3875. [ PubMed ]

Heinz A., Siessmeier T., Wrase J., Hermann D., Klein S., Grusser SM, Flor H., Braus DF, Buchholz HG, Grunder G., Schreckenberger M., Smolka MN, Rosch F., Mann K., Bartenstein P. Daidaita tsakanin mai karɓa na dopamine a cikin barasa na tsakiya (Bartenstein P.2). alamomi da sha'awa. Am. J. Likitan tabin hankali. 2004; 161:1783–1789. [ PubMed ]

Innis RB, Cunningham VJ, Delforge J., Fujita M., Gjedde A., Gunn RN, Holden J., Houle S., Huang SC, Ichise M., Iida H., Ito H., Kimura Y., Koeppe RA, Knudsen GM, Knuuti J., Lammertsma AA, Laruelle M., Logan J., Maguire RP, Mintun MA, Morris ED, Parsey R., Price JC, Slifstein M., Sossi V., Suhara T., Votaw JR, Wong DF, Carson RE Consensus nomenclature don hoton in vivo na radioligands masu ɗaurewa da za a iya juyawa. J. Cereb. Blood Flow Metab. 2007;27:1533–1539. [ PubMed ]

Ito H., Hietala J., Blomqvist G., Halldin C., Farde L. Kwatanta daidaiton wucin gadi da hanyar jiko mai ci gaba don nazarin PET mai yawa na ɗaurewar [11C]raclopride. J. Cereb. Blood Flow Metab. 1998;18:941–950. [ PubMed ]

Joutsa J., Johansson J., Niemela S., Ollikainen A., Hirvonen MM, Piepponen P., Arponen E., Alho H., Voon V., Rinne JO, Hietala J., Kaasinen V. Mesolimbic dopamine saki yana da nasaba da tsananin alama a cikin caca pathological. Neuroimage. 2012;60:1992-1999. [ PubMed ]

Kessler RC, Hwang I., LaBrie R., Petukhova M., Sampson NA, Winters KC, Shaffer HJ DSM-IV caca ta pathological a cikin Kwafi na Binciken Cututtukan Ƙasa. Psychol. Med. 2008;38:1351–1360. [ PubMed ]

Kim JH, Son YD, Kim HK, Lee SY, Cho SE, Kim YB, Cho ZH Tasirin shekaru akan samuwar masu karɓar dopamine D(2) a cikin sassan striatal: Nazarin tomography mai ƙuduri mai girma na positron. Eur. Neuropsychopharmacol. 2011;21:885–891. [ PubMed ]

Lee B., London ED, Poldrack RA, Farahi J., Nacca A., Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M., Mukherjee J., Bilder RM, Brody AL, Mandelkern MA Kasancewar masu karɓar ƙwayoyin cuta na Striatal dopamine d2/d3 yana raguwa a cikin dogaro da methamphetamine kuma yana da alaƙa da rashin ƙarfi. J. Neurosci. 2009;29:14734–14740. [ PubMed ]

Leeman RF, Potenza MN Kamanceceniya da bambance-bambance tsakanin caca ta hanyar cututtuka da cututtukan amfani da miyagun ƙwayoyi: mai da hankali kan rashin himma da tilastawa. Psychopharmacology (Berl) 2012;219:469–490. [ PubMed ]

Lesieur HR, Blume SB Allon Caca na South Oaks (SOGS): sabon kayan aiki don gano masu caca da ke da alaƙa da cutar. Am. J. Psychiatry. 1987;144:1184–1188. [ PubMed ]

Linnet J., Moller A., ​​Peterson E., Gjedde A., Doudet D. Sakin Dopamine a cikin ventral striatum yayin caca a Iowa Aikin da aka yi yana da alaƙa da ƙaruwar matakan farin ciki a cikin caca ta hanyar cututtuka. Addiction. 2011;106:383–390. [ PubMed ]

Martinez D., Slifstein M., Broft A., Mawlawi O., Hwang DR, Huang Y., Cooper T., Kegeles L., Zarahn E., Abi-Dargham A., Haber SN, Laruelle M. Hoton watsa kwayar halittar dopamine ta mesolimbic ta ɗan adam tare da hoton positron emission tomography. Kashi na II: sakin dopamine da amphetamine ya haifar a cikin sassan aiki na striatum. J. Cereb. Blood Flow Metab. 2003;23:285–300. [ PubMed ]

Martinez D., Broft A., Foltin RW, Slifstein M., Hwang DR, Huang Y., Perez A., Frankle WG, Cooper T., Kleber HD, Fischman MW, Laruelle M. Dogaro da cocaine da samuwar masu karɓar d2 a cikin sassan aiki na striatum: dangantaka da halayen neman cocaine. Neuropsychopharmacology. 2004;29:1190–1202. [ PubMed ]

Martinez D., Greene K., Broft A., Kumar D., Liu F., Narendran R., Slifstein M., Van Heertum R., Kleber HD Ƙananan matakan dopamine na endogenous a cikin marasa lafiya da suka dogara da cocaine: binciken da aka samu daga hoton PET na masu karɓar D(2)/D(3) bayan raguwar dopamine mai tsanani. Am. J. Psychiatry. 2009;166:1170–1177. [ PubMed ]

Matsumoto M., Togashi H., Kaku A., Kanno M., Tahara K., Yoshioka M. Tsarin GABAergic na martanin dopaminergic ga damuwa ta tunani a cikin yanayin beraye. Synapse. 2005;56:117–121. [ PubMed ]

McElroy SL, Nelson EB, Welge JA, Kaehler L., Keck PE, Jr. Olanzapine a cikin maganin caca ta hanyar cututtuka: gwajin da aka yi bazuwar da placebo ke sarrafawa. J. Clin. Psychiatry. 2008;69:433–440. [ PubMed ]

Meyer G., Schwertfeger J., Exton MS, Janssen OE, Knapp W., Stadler MA, Schedlowski M., Kruger TH Amsar Neuroendocrine ga caca a gidan caca a cikin masu matsalar caca. Psychoneuroendocrinology. 2004;29:1272–1280. [ PubMed ]

Michalczuk R., Bowden-Jones H., Verdejo-Garcia A., Clark L. Rashin sha'awa da karkacewar fahimta ga masu caca da ke halartar Asibitin Caca na Ƙasa na Burtaniya: rahoton farko. Psychol. Med. 2011;41:2625–2635. [ Labarin PMC kyauta ] [ PubMed ]

Montgomery AJ, Thielemans K., Mehta MA, Turkheimer F., Mustafovic S., Grasby PM Gyaran motsin kai akan nazarin PET: kwatanta hanyoyin. J. Nucl. Med. 2006;47:1936–1944. [ PubMed ]

Nader MA, Morgan D., Gage HD, Nader SH, Calhoun TL, Buchheimer N., Ehrenkaufer R., Mach RH PET hoton masu karɓar dopamine D2 yayin shan cocaine na yau da kullun a cikin birai. Nat. Neurosci. 2006;9:1050–1056. [ PubMed ]

O'Sullivan SS, Wu K., Politis M., Lawrence AD, Evans AH, Bose SK, Djamshidian A., Lees AJ, Piccini P. Sakin dopamine mai tsauri da Cue ke haifarwa a cikin halayen tilastawa da ke da alaƙa da cutar Parkinson. Kwakwalwa. 2011;134:969–978. [ PubMed ]

Reuter J., Raedler T., Rose M., Hand I., Glascher J., Buchel C. Caca ta hanyar cututtuka tana da alaƙa da rage kunna tsarin lada na mesolimbic. Nat. Neurosci. 2005;8:147–148. [ PubMed ]

Shaffer HJ, LaBrie R., Scanlan KM, Cummings TN Pathological Caca a tsakanin matasa: Screen Massachusetts Caca (MAGS) J. Gambl. Karatu. 1994; 10: 339 – 362.

Sheehan DV, Lecrubier Y., Sheehan KH, Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar GC Hira da Mini-International Neuropsychiatric Interview (MINI): haɓakawa da tabbatar da hirar da aka tsara ta hanyar binciken tabin hankali don DSM-IV da ICD-10. J. Clin. Psychiatry. 1998;59(Kayayyakin 20):22–33. [ PubMed ]

Slutske WS, Caspi A., Moffitt TE, Poulton R. Halayya da matsalar caca: wani bincike mai yiwuwa game da ƙungiyar haihuwa ta matasa. Arch. Gen. Psychiatry. 2005;62:769–775. [ PubMed ]

Smith N., Kitchenham N., Bowden-Jones H. Caca ta cututtuka da kuma maganin tabin hankali da aripiprazole: rahotannin shari'o'i. Br. J. Psychiatry. 2011;199:158–159. [ PubMed ]

Steeves TD, Miyasaki J., Zurowski M., Lang AE, Pellecchia G., Van Eimeren T., Rusjan P., Houle S., Strafella AP Ƙara yawan sakin dopamine mai ƙarfi a cikin marasa lafiya da ke fama da cutar Parkinsonian da ke fama da caca ta hanyar cututtuka: nazarin PET na [11C] raclopride. Kwakwalwa. 2009;132:1376–1385. [ PubMed ]

Stewart SH, Zack M. Ci gaba da kimantawa ta tunani game da Tambayoyi game da Manufofin Caca masu girma uku. Jaraba. 2008;103:1110–1117. [ PubMed ]

Stokes PR, Egerton A., Watson B., Reid A., Breen G., Lingford-Hughes A., Nutt DJ, Mehta MA Raguwar da ke faruwa a gaba da kuma na lokaci [11C]-raclopride bayan ƙalubalen THC. Neuroimage. 2010;52:1521–1527. [ PubMed ]

Verdejo-Garcia A., Lawrence AJ, Clark L. Rashin sha'awa a matsayin alamar rauni ga cututtukan amfani da miyagun ƙwayoyi: bita na binciken da aka samu daga bincike mai haɗari, matsalolin 'yan caca da nazarin haɗin gwiwar kwayoyin halitta. Neurosci. Biobehav. Rev. 2008;32:777–810. [ PubMed ]

Volkow ND, Wang GJ, Fowler JS, Logan J., Gatley SJ, Hitzemann R., Chen AD, Dewey SL, Pappas N. Rage amsawar dopaminergic na striatal a cikin mutanen da suka dogara da cocaine da aka cire daga jiki. Yanayi. 1997;386:830–833. [ PubMed ]

Volkow ND, Wang GJ, Fowler JS, Logan J., Gatley SJ, Gifford A., Hitzemann R., Ding YS, Pappas N. Hasashen ƙarfafa martani ga masu motsa rai a cikin mutane ta hanyar matakan masu karɓar dopamine D2 na kwakwalwa. Am. J. Psychiatry. 1999;156:1440–1443. [ PubMed ]

Volkow ND, Chang L., Wang GJ, Fowler JS, Ding YS, Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., Pappas N. Ƙananan matakan masu karɓar dopamine D2 na kwakwalwa a cikin masu cin zarafin methamphetamine: alaƙa da metabolism a cikin orbitofrontal cortex. Am. J. Psychiatry. 2001;158:2015–2021. [ PubMed ]

Voon V., Fernagut PO, Wickens J., Baunez C., Rodriguez M., Pavon N., Juncos JL, Obeso JA, Bezard E. Ƙarfafa dopaminergic na yau da kullun a cikin cutar Parkinson: daga dyskinesias zuwa rikice-rikicen sarrafa motsin rai. Lancet Neurol. 2009;8:1140–1149. [ PubMed ]

Wang GJ, Volkow ND, Logan J., Pappas NR, Wong CT, Zhu W., Netusil N., Fowler JS Kwakwalwar dopamine da kiba. Lancet. 2001;357:354–357. [ PubMed ]

Watabe H., Endres CJ, Breier A., ​​Schmall B., Eckelman WC, Carson RE. Ma'aunin sakin dopamine tare da ci gaba da shigar da [11C]raclopride: ingantawa da la'akari da sigina zuwa hayaniya. J. Nucl. Med. 2000;41:522–530. [ PubMed ]

Zald DH, Boileau I., El-Dearedy W., Gunn R., McGlone F., Dichter GS, Dagher A. Yaɗuwar dopamine a cikin yanayin ɗan adam yayin ayyukan lada na kuɗi. J. Neurosci. 2004;24:4105–4112. [ PubMed ]